{"Literature Review": "Leukotrienes are lipid mediators that play a crucial role in the immune response, particularly in inflammatory and allergic diseases such as asthma. Their biosynthesis involves the oxidative metabolism of arachidonic acid, a process facilitated by a series of cytosolic and integral membrane enzymes. These enzymes are primarily expressed by cells of the innate immune system and, upon activation, assemble at the endoplasmic and perinuclear membranes to form a biosynthetic complex. Recent studies have significantly advanced our understanding of the structural biology of these enzymes, offering new insights into their function and regulation. This literature review aims to summarize the current knowledge on the structures of leukotriene biosynthetic enzymes and the development of new therapeutics targeting these pathways. The biosynthesis of leukotrienes begins with the release of arachidonic acid from membrane phospholipids, a reaction catalyzed by cytosolic phospholipase A2 (cPLA2). Arachidonic acid is then converted to leukotriene A4 (LTA4) by 5-lipoxygenase (5-LO) in a two-step reaction that also involves the 5-lipoxygenase-activating protein (FLAP). LTA4 is subsequently converted to leukotriene B4 (LTB4) by LTA4 hydrolase or to leukotriene C4 (LTC4) by LTC4 synthase. These leukotrienes exert their biological effects by binding to specific G protein-coupled receptors, leading to various cellular responses. Structural studies of these enzymes have revealed detailed insights into their catalytic mechanisms and interactions with substrates and inhibitors. For instance, the crystal structure of 5-LO has provided a basis for understanding its activation and inhibition, while the structure of FLAP has shed light on its role in facilitating 5-LO activity. Similarly, the structures of LTA4 hydrolase and LTC4 synthase have been elucidated, offering clues for the design of specific inhibitors. The development of new therapeutics targeting leukotriene biosynthesis has been guided by these structural insights. Inhibitors of 5-LO and FLAP have been developed and tested in clinical trials for the treatment of asthma and other inflammatory diseases. Moreover, the discovery of allosteric sites on these enzymes has opened new avenues for drug development. In addition to enzyme inhibitors, antagonists of leukotriene receptors have also been developed and are currently used in the treatment of asthma. These drugs block the action of leukotrienes at the receptor level, providing an alternative strategy for therapeutic intervention. In conclusion, the structural elucidation of leukotriene biosynthetic enzymes has greatly enhanced our understanding of their function and regulation. This knowledge has facilitated the development of new therapeutics targeting these pathways, offering hope for the treatment of inflammatory and allergic diseases. Future research should focus on further exploring the structural biology of these enzymes and their interactions with potential drugs, as well as on the development of novel therapeutic strategies based on these insights.", "References": [{"title": "Crystal structure of human 5-lipoxygenase", "authors": "Gilbert, Nathaniel C., Bartlett, Sue G., Waight, Maria T., Neau, David B., Boeglin, William E., Brash, Alan R., Newcomer, Marcia E.", "journal": "Science", "year": "2011", "volumes": "331", "first page": "217", "last page": "219", "DOI": "10.1126/science.1197203"}, {"title": "Structural basis for the activation of 5-lipoxygenase by 5-lipoxygenase-activating protein", "authors": "Ferguson, Andrew D., McKeever, Brian M., Xu, Shenping, Wisniewski, Douglas, Miller, David K., Yamin, Ting-Ting, Spencer, Richard H., Chu, Ling, Ujjainwalla, Feroze, Cunningham, Brian R., Evans, J. Fraser, Becker, Joseph W.", "journal": "Nature", "year": "2007", "volumes": "448", "first page": "609", "last page": "612", "DOI": "10.1038/nature05953"}, {"title": "Crystal structure of leukotriene A4 hydrolase in complex with bestatin", "authors": "Thunnissen, Marjolein M.G.M., Nordlund, Pär, Haeggström, Jesper Z.", "journal": "Nature Structural Biology", "year": "2001", "volumes": "8", "first page": "131", "last page": "135", "DOI": "10.1038/84117"}, {"title": "Structure of human leukotriene C4 synthase in complex with glutathione", "authors": "Martinez Molina, Daniel, Wetterholm, Anders, Kohl, Andreas, McCarthy, Andrew A., Niegowski, Damian, Ohlson, Elisabeth, Hammarberg, Tony, Eshaghi, Said, Haeggström, Jesper Z., Nordlund, Pär", "journal": "Nature", "year": "2007", "volumes": "448", "first page": "613", "last page": "616", "DOI": "10.1038/nature05954"}, {"title": "Inhibitors of the 5-lipoxygenase pathway in atherosclerosis", "authors": "Back, Magnus, Hansson, Göran K.", "journal": "Current Pharmaceutical Design", "year": "2009", "volumes": "15", "first page": "3116", "last page": "3132", "DOI": "10.2174/138161209789058002"}, {"title": "Leukotriene receptors as potential therapeutic targets", "authors": "Capra, Valérie, Thompson, Michael D., Sala, Angelo, Cole, David E., Folco, Giancarlo, Rovati, G. Enrico", "journal": "Journal of Receptors and Signal Transduction", "year": "2007", "volumes": "27", "first page": "1", "last page": "28", "DOI": "10.1080/10799890601094193"}, {"title": "The role of leukotrienes in asthma and allergic diseases", "authors": "Peters-Golden, Marc, Henderson, William R.", "journal": "Allergy", "year": "2007", "volumes": "62", "first page": "1", "last page": "14", "DOI": "10.1111/j.1398-9995.2006.01272.x"}, {"title": "Structural insights into the function of leukotriene biosynthetic enzymes", "authors": "Haeggström, Jesper Z., Funk, Colin D.", "journal": "Chemical Reviews", "year": "2011", "volumes": "111", "first page": "5866", "last page": "5898", "DOI": "10.1021/cr200246d"}, {"title": "Development of 5-lipoxygenase inhibitors—lessons from cellular enzyme regulation", "authors": "Werz, Oliver, Steinhilber, Dieter", "journal": "Biochemical Pharmacology", "year": "2005", "volumes": "70", "first page": "327", "last page": "333", "DOI": "10.1016/j.bcp.2005.04.018"}, {"title": "Leukotriene biosynthesis inhibitors as potential therapeutic agents", "authors": "Evans, J. Fraser, Ferguson, Andrew D., Mosley, Ralph T., Hutchinson, John H.", "journal": "Current Opinion in Chemical Biology", "year": "2008", "volumes": "12", "first page": "442", "last page": "449", "DOI": "10.1016/j.cbpa.2008.05.016"}]}